IP Library Granted Patent US 8,497,088
Granted Patent B2
US 8,497,088 · App. 12/528,695 · Granted Jul 30, 2013

Process for the preparation of beta-lactam compounds

Inventors: Thomas Van Der Does (Wilnis, NL); Harold Monro Moody (Gulpen, NL); Theodorus Johannes Godfried Maria Van Dooren (Roermond, NL)
Assignee: DSM Sinochem Pharmaceuticals Netherlands B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,497,088
App. No.
12/528,695
Granted
Jul 30, 2013
Kind
B2
Abstract

The present invention describes a process for the synthesis of a semi-synthetic β-lactam compound from a nucleus and a side chain selected from the group consisting of D-phenylglycine and D-dihydro-phenylglycine in the form of a side chain ester and an enzyme catalyzing the coupling of the side chain ester to the nucleus characterized in that the side chain ester is not isolated as a solid intermediate.

Claims (12)

1. A process for the synthesis of a semi-synthetic β-lactam compound from a nucleus and a side chain selected from the group consisting of D-phenylglycine and D-dihydro-phenylglycine in the form of a side chain ester and an enzyme catalyzing the coupling of the side chain ester to the nucleus comprising the steps of

(a) converting a free side chain selected from the group consisting of D-phenylglycine and D-dihydro-phenylglycine with an alcohol to form a mixture comprising the corresponding side chain ester;

(b) forming the semi-synthetic β-lactam compound by mixing the mixture obtained in step (a) with a nucleus and the enzyme to form the semi-synthetic β-lactam compound,

with the proviso that the side chain ester formed in step (a) is not isolated as a solid intermediate.

2. Process according to claim 1 wherein the mixture obtained in step (a) is purified before forming the semi-synthetic β-lactam compound in step (b).

3. Process according to claim 1 wherein the nucleus is selected from the group consisting of 6-aminopenicillanic acid (6-APA), 7-amino-deacetoxy-cephalosporanic acid (7-ADCA), 7-aminocephalosporanic acid (7-ACA) and 7-amino-3-chloro-3-cephem-4-carboxylate (7-ACCA).

4. Process according to claim 1 wherein the semi-synthetic β-lactam compound is selected from the group consisting of Ampicillin, Cephalexin, Cephradine and Cefaclor.

5. Process according to claim 1 wherein the alcohol is methanol or ethanol.

6. Process according to claim 5 wherein the alcohol is methanol.

7. Process according to claim 1 wherein the enzyme is a penicillin G acylase.

8. Process according to claim 7 wherein the penicillin G acylase is from Escherichia coli.

9. Process according to claim 7 wherein the enzyme is in an immobilized form.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2012
From: DSM IP ASSETS B.V.
To: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.
Reel/Frame 028638/0486 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2010
From: VAN DER DOES, THOMAS; MOODY, HAROLD MONRO; VAN DOOREN, THEODORUS J.G.M.
To: DSM IP ASSETS B.V.
Reel/Frame 023881/0625 →
Priority Claims (1)
EP 07103850 · Mar 9, 2007 · regional
Continuity (1)
Related Publication 20110104748A1 · May 5, 2011